Gene therapy of cardiovascular disease

Area of Science:

• Cardiovascular Medicine
• Regenerative Medicine
• Gene Therapy

Background:

• Coronary and peripheral artery diseases are prevalent, with limited treatment options for advanced stages.
• Current treatments face challenges in vessel regeneration and preventing post-angioplasty restenosis.
• Therapeutic angiogenesis and gene therapy have been researched for over 17 years.

Purpose of the Study:

• To review the development of gene therapy strategies for cardiovascular diseases over the past 7 years.
• To evaluate the efficacy of gene therapy in animal models and clinical trials.
• To highlight advancements in therapeutic angiogenesis and restenosis prevention.

Main Methods:

• Review of preclinical animal studies on gene therapy for cardiovascular applications.
• Analysis of data from Phase II clinical trials investigating gene therapy interventions.
• Examination of research trends in therapeutic angiogenesis and local gene therapy.

Main Results:

• Gene therapy has shown potential in preclinical models for vessel regeneration.
• Phase II clinical trials have provided valuable data on the safety and efficacy of gene therapy approaches.
• Significant research efforts have focused on developing gene therapy to prevent post-angioplasty restenosis.

Conclusions:

• Gene therapy represents a promising therapeutic avenue for advanced cardiovascular diseases.
• Further research and clinical trials are essential to optimize gene therapy strategies.
• Gene therapy holds potential for both vessel regeneration and preventing restenosis after angioplasty.